These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16356799)

  • 1. Recurrence of lymphoma presenting as asymmetrically increased testicular activity on FDG-PET/CT.
    Kuo PH; Cooper DL; Cheng DW
    Semin Nucl Med; 2006 Jan; 36(1):105-7. PubMed ID: 16356799
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary testicular lymphoma involving the spermatic cord and gonadal vein.
    Scalcione LR; Katz DS; Santoro MS; Mahboob S; Badler RL; Yung EY
    Clin Nucl Med; 2009 Apr; 34(4):222-3. PubMed ID: 19300051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of PET and PET/CT in managing the care of lymphoma patients.
    Evans WC; Gilmore D; English J
    J Nucl Med Technol; 2011 Sep; 39(3):190-4. PubMed ID: 21795369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal and abnormal patterns of 18F-fluorodeoxyglucose PET/CT in lymphoma.
    Bar-Shalom R
    Radiol Clin North Am; 2007 Jul; 45(4):677-88, vi-vii. PubMed ID: 17706532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [18F-FDG-PET-CT in soft tissue sarcomas: when to image?].
    Rodríguez-Alfonso B; Mucientes Rasilla J; Mitjavila Casanovas M; Cardona Arboniés J; Cubedo R
    Rev Esp Med Nucl Imagen Mol; 2014; 33(1):43-9. PubMed ID: 24094372
    [No Abstract]   [Full Text] [Related]  

  • 6. Melanoma metastasis to the testis demonstrated with FDG PET/CT.
    Weng LJ; Schöder H
    Clin Nucl Med; 2004 Dec; 29(12):811-2. PubMed ID: 15545888
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse.
    Hain SF; O'Doherty MJ; Timothy AR; Leslie MD; Harper PG; Huddart RA
    Br J Cancer; 2000 Oct; 83(7):863-9. PubMed ID: 10970686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDG PET/CT of bilateral testicular lymphoma.
    Dang CJ; Zhan FH; Li YJ
    Clin Nucl Med; 2012 Jan; 37(1):95-7. PubMed ID: 22157041
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of flourine-18 fluorodeoxyglucose positron emission tomography in thymic pathology.
    El-Bawab H; Al-Sugair AA; Rafay M; Hajjar W; Mahdy M; Al-Kattan K
    Eur J Cardiothorac Surg; 2007 Apr; 31(4):731-6. PubMed ID: 17293120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoma grading with FDG-PET/CT readdressed: Direct and timely histopathological correlation study.
    Adams HJ; de Klerk JM; Fijnheer R; Heggelman BG; Dubois SV; Nievelstein RA; Kwee TC
    Acta Oncol; 2016; 55(3):386-90. PubMed ID: 25975211
    [No Abstract]   [Full Text] [Related]  

  • 11. Response from authors of "reliability of post-chemoradiotherapy F-18-FDG PET/CT for prediction of locoregional failure in human papillomavirus-associated oropharyngeal cancer".
    Vainshtein JM; Eisbruch A
    Oral Oncol; 2014 Jul; 50(7):e30. PubMed ID: 24747033
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of FDG-PET/CT imaging after radiation therapy.
    Grigsby PW
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S27-9. PubMed ID: 17727930
    [No Abstract]   [Full Text] [Related]  

  • 13. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in urological cancers].
    Bourguet P;
    Bull Cancer; 2003 Feb; 90 Spec No():S80-7. PubMed ID: 12739339
    [No Abstract]   [Full Text] [Related]  

  • 14. Nonossifying fibroma can mimic residual lymphoma in FDG PET: additional value of combined PET/CT.
    von Falck C; Rosenthal H; Gratz KF; Galanski M
    Clin Nucl Med; 2007 Aug; 32(8):640-2. PubMed ID: 17667441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability of post-chemo radiotherapy F-18-FDG PET/CT for prediction of loco regional failure in human papillomavirus-associated oropharyngeal cancer: misconception and misinterpretation.
    Sabour S
    Oral Oncol; 2014 Jul; 50(7):e29. PubMed ID: 24775610
    [No Abstract]   [Full Text] [Related]  

  • 16. Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging in patients with carcinoma of the nasopharynx: diagnostic accuracy and impact on clinical management.
    Gordin A; Golz A; Daitzchman M; Keidar Z; Bar-Shalom R; Kuten A; Israel O
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):370-6. PubMed ID: 17324532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent hepatic epithelioid hemangioendothelioma: detection by FDG PET/CT.
    Lin E; Agoff N
    Clin Nucl Med; 2007 Dec; 32(12):949-51. PubMed ID: 18030050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
    Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
    PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The more you look, the more you find: challenging results on FDG-PET CT in a patient with neurofibromatosis type I.
    Schöffski P; Deroose CM; Gheysens O; Lips N; Slabbaert K; Vancleynenbreugel B; Moerman P; Peetermans WE
    BMC Med Imaging; 2014 May; 14():19. PubMed ID: 24885974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re: 18F-FDG PET/CT Impact on Testicular Tumours Clinical Management.
    Richie JP
    J Urol; 2015 Oct; 194(4):991. PubMed ID: 26382779
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.